Investors Don't See Light At End Of Sphere Power Inc.'s (KOSDAQ:203690) Tunnel And Push Stock Down 29%
May 06
South Korean (KOSPI) Biotech Industry Analysis
UpdatedMay 06, 2024
DataAggregated Company Financials
Companies115
- 7D4.2%
- 3M11.5%
- 1Y7.3%
- YTD-8.0%
The Biotech industry is up 4.2% in the last week, with Celltrion up 2.9%. In the same time, Hugel was down 9.0%. This takes the industry's 12 month performance to a gain of 7.3%. Looking forward, earnings are forecast to grow by 48% annually.
Industry Valuation and Performance
Has the South Korean Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 06 May 2024 | ₩82.4t | ₩9.6t | -₩567,818,034,968.00 | 22.4x | -145.1x | 8.6x |
| Wed, 03 Apr 2024 | ₩80.8t | ₩9.6t | -₩665,568,465,312.00 | 19.6x | -121.5x | 8.4x |
| Fri, 01 Mar 2024 | ₩78.2t | ₩9.7t | -₩534,696,541,747.00 | 58.3x | -146.2x | 8x |
| Sun, 28 Jan 2024 | ₩73.9t | ₩9.7t | -₩537,261,689,777.00 | 63.5x | -137.6x | 7.6x |
| Tue, 26 Dec 2023 | ₩63.6t | ₩10.1t | -₩324,942,076,247.00 | 28.5x | -195.8x | 6.3x |
| Thu, 23 Nov 2023 | ₩59.1t | ₩10.2t | -₩254,861,267,409.00 | 27.2x | -231.8x | 5.8x |
| Sat, 21 Oct 2023 | ₩51.1t | ₩10.2t | -₩239,053,318,689.00 | 28.9x | -213.6x | 5x |
| Mon, 18 Sep 2023 | ₩59.1t | ₩10.2t | -₩339,708,651,659.00 | 32.3x | -174x | 5.8x |
| Wed, 16 Aug 2023 | ₩60.0t | ₩10.3t | -₩166,187,036,659.00 | 30.5x | -361.1x | 5.8x |
| Fri, 14 Jul 2023 | ₩57.5t | ₩10.3t | -₩151,534,704,579.00 | 27.5x | -379.3x | 5.6x |
| Sun, 11 Jun 2023 | ₩62.7t | ₩10.3t | -₩151,338,675,579.00 | 29.6x | -414.3x | 6.1x |
| Tue, 09 May 2023 | ₩61.6t | ₩11.0t | ₩317.9b | 25x | 193.8x | 5.6x |
| Thu, 06 Apr 2023 | ₩61.1t | ₩11.0t | ₩317.7b | 24.7x | 192.2x | 5.6x |
| Sat, 04 Mar 2023 | ₩57.6t | ₩11.3t | ₩968.2b | 24.3x | 59.5x | 5.1x |
| Mon, 30 Jan 2023 | ₩59.9t | ₩11.3t | ₩970.8b | 24.5x | 61.7x | 5.3x |
| Wed, 28 Dec 2022 | ₩60.0t | ₩11.4t | ₩678.5b | 23.9x | 88.5x | 5.3x |
| Fri, 25 Nov 2022 | ₩61.2t | ₩11.0t | ₩298.7b | 20.9x | 204.9x | 5.6x |
| Sun, 23 Oct 2022 | ₩56.9t | ₩10.8t | ₩348.0b | 19.2x | 163.5x | 5.3x |
| Tue, 20 Sep 2022 | ₩60.7t | ₩10.8t | ₩495.4b | 22.3x | 122.4x | 5.6x |
| Thu, 18 Aug 2022 | ₩74.4t | ₩10.7t | ₩578.1b | 24.4x | 128.7x | 7x |
| Sat, 16 Jul 2022 | ₩71.2t | ₩10.7t | ₩597.6b | 24.5x | 119.1x | 6.7x |
| Mon, 13 Jun 2022 | ₩66.4t | ₩10.6t | ₩626.3b | 27.1x | 106x | 6.2x |
| Wed, 11 May 2022 | ₩65.5t | ₩10.0t | ₩866.3b | 25x | 75.6x | 6.6x |
| Fri, 08 Apr 2022 | ₩73.1t | ₩10.0t | ₩898.1b | 27.2x | 81.4x | 7.3x |
| Sun, 06 Mar 2022 | ₩73.6t | ₩9.4t | ₩769.1b | 34.5x | 95.7x | 7.8x |
| Tue, 01 Feb 2022 | ₩72.4t | ₩9.4t | ₩787.4b | 31.6x | 91.9x | 7.7x |
| Thu, 30 Dec 2021 | ₩92.5t | ₩9.4t | ₩787.4b | 40.2x | 117.4x | 9.9x |
| Sat, 27 Nov 2021 | ₩97.5t | ₩9.3t | ₩1.0t | 31.6x | 95.7x | 10.5x |
| Mon, 25 Oct 2021 | ₩97.4t | ₩9.2t | ₩986.0b | 39.8x | 98.8x | 10.6x |
| Wed, 22 Sep 2021 | ₩116.6t | ₩9.2t | ₩986.1b | 43.8x | 118.2x | 12.7x |
| Fri, 20 Aug 2021 | ₩116.5t | ₩9.3t | ₩909.7b | 48.9x | 128.1x | 12.5x |
| Fri, 04 Jun 2021 | ₩101.8t | ₩9.0t | ₩979.0b | 45.3x | 104x | 11.3x |
Price to Earnings Ratio
104x
Current Industry PE
- Investors are optimistic on the South Korean Biotechs industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 7.4x is lower than the industry's current PS ratio of 8.6x.
Past Earnings Growth
- Total earnings for the Biotechs industry have declined over the last three years, with the industry now making a loss overall.
- Meanwhile revenues have grown 2.2% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the South Korean Healthcare industry?
| KR Market | 0.83% | |
| Healthcare | 1.93% | |
| Biotech | 4.17% | |
| Biotech | 4.17% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| A068270 Celltrion | ₩189.00k | 2.9% +₩1.1t | 16.4% | PE73.1x | |
| A214450 PharmaResearch | ₩139.60k | 8.6% +₩124.0b | 37.1% | PE18.7x | |
| A950160 Kolon TissueGene | ₩12.43k | 6.7% +₩57.9b | 17.0% | n/a | |
| A196170 ALTEOGEN | ₩177.20k | 0.4% +₩37.1b | 291.6% | PS97.3x | |
| A007390 NatureCellLtd | ₩9.38k | 4.9% +₩28.2b | -13.1% | PS31.1x |
